BackUrinary and Reproductive System Infections: Microbiology Study Notes
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Urinary and Reproductive System Infections
Overview
This chapter focuses on the microbiology of urinary and reproductive system infections, including bacterial, fungal, and parasitic pathogens. It covers the etiology, transmission, clinical manifestations, complications, and treatment of key infectious diseases affecting these systems.
Reproductive System Bacterial Infections
Syphilis
Syphilis is a common but curable sexually transmitted infection (STI) caused by the spirochete Treponema pallidum.
Etiological Agent: Treponema pallidum (Gram-negative spirochete)
Characteristics: Very few surface antigens, allowing evasion of the immune response; reinfection is possible.
Transmission: Direct contact with infectious chancres (ulcerative lesions).
Risk Groups
Men who have sex with men (MSM)
Men who have sex with women only
Women
Men without data on sex of partner
Clinical Progression
Primary Stage: Chancre at infection site, possible invasion of the central nervous system, subsides in 4–6 weeks. The immune system does not usually eliminate all bacteria.
Secondary Stage: Occurs ~3 months after infection. Symptoms include rash, condylomata lata (wart-like genital/anal lesions), swollen lymph nodes, sore throat, patchy hair loss, fever, muscle aches, malaise. Symptoms resolve within 3 months, followed by a latent period lasting months to years.
Tertiary Stage: May occur years later. Characterized by gummatous lesions on skin and bones, cardiovascular and neurological symptoms (insomnia, vertigo, seizures, paralysis, memory impairment, hallucinations). Can be fatal.
Treatment and Prevention
Treatment: Curable with antibiotics (e.g., penicillin). All sexual partners must be treated.
Prevention: Safe sexual practices and routine screening.
Clinical Vocabulary
Chancre: Ulcer-like lesion, often on genitalia, associated with syphilis.
Condylomata lata: Wart-like genital lesions.
Disease Snapshot: Syphilis
Causative Agent | Treponema pallidum (Gram-negative spirochete) |
|---|---|
Epidemiology | Most U.S. cases in men who have sex with men; incubation 10–90 days; vertical transmission possible |
Transmission & Prevention | Sexual contact with infectious lesions; prevention includes safe sex, screening, and partner treatment |
Signs & Symptoms | Primary: chancre; Secondary: rash, condylomata lata, systemic symptoms; Tertiary: gummas, neurological/cardiac symptoms |
Diagnosis & Treatment | Serology, microscopy; penicillin G or Bicillin L-A |
Congenital Syphilis
Transmission: Mother-to-fetus during pregnancy
Signs and Symptoms:
2–10 weeks after birth: skin lesions, bloody nasal discharge
Up to 2 years later: nasal, tooth, or palate deformities; blindness or deafness
Complications: Fetal death, birth defects, or infected infants if untreated
Treatment: Maternal antibiotic therapy (Bicillin L-A) can prevent fetal infection
Prevention: Routine prenatal screening
Chancroid
Etiological Agent: Haemophilus ducreyi (Gram-negative, nonmotile rods)
Characteristics: Rare in developed countries; common cofactor for HIV transmission
Signs and Symptoms: Painful genital ulcers, genital lymph node buboes
Treatment: Antibiotics (macrolides, cephalosporins, fluoroquinolones)
Reproductive System Eukaryotic Infections
Candidiasis (Yeast Infection)
Etiological Agent: Candida albicans (dimorphic, opportunistic fungus)
Characteristics: Most common fungal infection of the reproductive system; normal vaginal resident
Transmission: Dysbiosis due to antibiotics, hormonal changes, or other factors
Signs and Symptoms: Vaginal itching, burning, pain, "cottage cheese-like" discharge
Progression: Can invade urinary/reproductive organs; may become systemic
Mechanism of Disease: Morphogenesis to hyphal form in response to environmental changes (e.g., increased estrogen, pH shifts); hyphal yeast secrete proteases, causing cellular damage and inflammation
Complications: Biofilm formation increases resistance to treatment
Treatment: Antifungal suppositories, creams, or pills
Disease Snapshot: Candidiasis
Causative Agent | Usually Candida albicans |
|---|---|
Epidemiology | ~75% of women develop vulvovaginal candidiasis at some point |
Transmission & Prevention | Dysbiosis from antibiotics, hormonal changes, sexual transmission rare |
Signs & Symptoms | Itching, burning, pain, "cottage cheese" discharge |
Diagnosis & Treatment | Microscopy, antifungal therapy |
Trichomoniasis
Etiological Agent: Trichomonas vaginalis (motile, flagellated protist)
Characteristics: ~3.7 million cases in the U.S.; often asymptomatic
Transmission: Sexually transmitted
Signs and Symptoms:
Men: discharge, dysuria, urethral discomfort after ejaculation
Women: frothy, greenish discharge, dysuria, itchiness, soreness, vaginal burning
Complications: Infection during pregnancy can cause preterm labor and low-birth-weight babies
Diagnosis: Wet mount of vaginal discharge
Treatment: Metronidazole
Disease Snapshot: Trichomoniasis
Causative Agent | Trichomonas vaginalis |
|---|---|
Epidemiology | ~3.7 million U.S. cases; globally, ~277 million people infected |
Transmission & Prevention | Sexual transmission; prevention by safe sex, screening |
Signs & Symptoms | Often asymptomatic; discharge, dysuria, irritation |
Diagnosis & Treatment | Wet mount, DNA tests; metronidazole |
Visual Summary: Urinary and Reproductive Infections
This visual summary provides an overview of the main pathogens, symptoms, and treatments for urinary and reproductive system infections, emphasizing the importance of diagnosis, prevention, and appropriate antimicrobial therapy.
Additional Information
Routine screening and early treatment are essential for preventing complications and transmission of reproductive system infections.
Safe sexual practices and education are key public health strategies.